Home/smartbax/Dr. Sebastian Schreiber

DS

Dr. Sebastian Schreiber

Scientist

Therapeutic Areas

Infectious Disease Antimicrobial Resistance (AMR)

smartbax Pipeline

Drug	Indication	Phase
Undisclosed Novel Antibiotic Program(s)	Infections caused by multi-drug-resistant bacteria	Preclinical

Leadership Team at smartbax

Dr. Robert Macsics

Co-Founder, CEO

Dr. Kamal Kumar

Head of Medicinal Chemistry

Dr. Sylvia Varland

Senior Scientist

Dr. Eric Juskewitz

Senior Scientist

View full smartbax profile